Transcriptomic and proteomic studies have confirmed the presence of inflammatory and profibrogenic markers in high myopia and have identified some of the angiogenic/angiostatic factors linked to myopia progression and macular involvement, such as VEGF [21,22]. This evidence concerns the gene VEGFA and myopia.